Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Bortezomib Restores Defective Apoptosis by Upregulation of Noxa in Enteropathy-Associated T-Cell Lymphoma

Laura R de Baaij, MD, Marijn Radersma, MD, Jolanda MW van de Water, MD, Kim BJ Groot, Nathalie J Hijmering, Laura M Moesbergen, Otto J Visser, MD, Joost J Oudejans, MD, PhD, Chris JJ Mulder, MD, PhD, Chris JLM Meijer, MD, PhD, Saskia AGM Cillessen, PhD

Blood (2011) 118 (21): 2722.

https://doi.org/10.1182/blood.V118.21.2722.2722

Published: 2011

Journal Articles

Bortezomib Induces Caspase-9-Mediated Apoptosis through Activation of the BH3-Only Proteins Noxa, Bik and Puma In Both ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma Cells

Saskia AGM Cillessen, PhD, Nathalie J Hijmering, Laura M Moesbergen, Gert J. Ossenkoppele, MD, PhD, Joost J Oudejans, MD, PhD, Chris JLM Meijer, MD, PhD

Blood (2010) 116 (21): 2847.

https://doi.org/10.1182/blood.V116.21.2847.2847

Published: 2010

Journal Articles

Enteropathy-Associated T-Cell Lymphoma: a Clinical Prognostic Model to Identify High Risk Patients

Laura R de Baaij, MD, Jolanda MW van de Water, MD, Wieke HM Verbeek, MD, PhD, Otto J Visser, MD, Dirk J Kuik, Msc, Joost J Oudejans, MD, PhD, Chris JLM Meijer, MD, PhD, Chris JJ Mulder, MD, PhD, Saskia AGM Cillessen, PhD

Blood (2010) 116 (21): 3092.

https://doi.org/10.1182/blood.V116.21.3092.3092

Published: 2010

Journal Articles

Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression

Marielle J. Wondergem, Servi J.C. Stevens, Jeroen J.W.M. Janssen, Joost J. Oudejans, Gert J. Ossenkoppele, Jaap M. Middeldorp, Sonja Zweegman

Blood (2008) 111 (3): 1739.

https://doi.org/10.1182/blood-2007-09-111534

Published: 2008

Journal Articles

Small-molecule XIAP antagonist restores caspase-9–mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells

Saskia A. G. M. Cillessen, John C. Reed, Kate Welsh, Clemencia Pinilla, Richard Houghten, Erik Hooijberg, José Deurhof, Kitty C. M. Castricum, Pim Kortman, Corine J. Hess, Gert J. Ossenkoppele, Chris J. L. M. Meijer, Joost J. Oudejans

Blood (2008) 111 (1): 369–375.

https://doi.org/10.1182/blood-2007-04-085480

Published: 2008

Journal Articles

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity.

Saskia A.G.M. Cillessen, MSc, Wendy J.M. Mackus, PhD, Kitty C.M. Castricum, Wim Vos, Pim C. Kortman, Jan G.J. van de Winkel, PhD, Paul W.H.I. Parren, PhD, Chris J.L.M. Meijer, PhD, MD, Joost J. Oudejans, PhD, MD, (Intr. by Ole Baadsgaard)

Blood (2007) 110 (11): 2346.

https://doi.org/10.1182/blood.V110.11.2346.2346

Published: 2007

Journal Articles

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Saskia A.G.M. Cillessen, MSc, John C. Reed, PhD MD, Clemencia Pinilla, PhD, Chris J.L.M. Meijer, PhD MD, Erik Hooijberg, PhD, Corine J. Hess, MD, Kitty C.M. Castricum, Pim Kortman, Gert J. Ossenkoppele, PhD MD, Joost J. Oudejans, PhD MD

Blood (2007) 110 (11): 803.

https://doi.org/10.1182/blood.V110.11.803.803

Published: 2007

Journal Articles

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas

Jettie J. F. Muris, Saskia A. G. M. Cillessen, Wim Vos, Inge S. van Houdt, J. Alain Kummer, Johan H. J. M. van Krieken, N. Mehdi Jiwa, Patty M. Jansen, Hanneke C. Kluin-Nelemans, Gert J. Ossenkoppele, Chad Gundy, Chris J. L. M. Meijer, Joost J. Oudejans

Blood (2005) 105 (7): 2916–2923.

https://doi.org/10.1182/blood-2004-07-2716

Published: 2005

Journal Articles

Profiling of Caspase Signaling Pathways Predicts Clinical Response to Chemotherapy in Diffuse Large B-Cell Lymphomas.

Joost J. Oudejans, MD, PhD, Jettie J.F. Muris, MD, Gert J. Ossenkoppele, MD, PhD, Saskia A.G.M. Cillessen, Inge van Houdt, Alain J. Kummer, MD, PhD, Han van Krieken, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Chris J.L.M. Meijer, MD, PhD

Blood (2004) 104 (11): 1544.

https://doi.org/10.1182/blood.V104.11.1544.1544

Published: 2004

Journal Articles

High numbers of active caspase 3–positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome

Danny F. Dukers, Chris J. L. M. Meijer, Rosita L. ten Berge, Wim Vos, Gert J. Ossenkoppele, Joost J. Oudejans

Blood (2002) 100 (1): 36–42.

https://doi.org/10.1182/blood.V100.1.36

Published: 2002

Journal Articles

Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma

Rosita L. ten Berge, Chris J. L. M. Meijer, Danny F. Dukers, J. Alain Kummer, Bellinda A. Bladergroen, Wim Vos, C. Erik Hack, Gert J. Ossenkoppele, Joost J. Oudejans

Blood (2002) 99 (12): 4540–4546.

https://doi.org/10.1182/blood.V99.12.4540

Published: 2002

Journal Articles

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

Bellinda A. Bladergroen, Chris J. L. M. Meijer, Rosita L. ten Berge, C. Erik Hack, Jettie J. F. Muris, Danny F. Dukers, Andreas Chott, Yoshiaki Kazama, Joost J. Oudejans, Oskar van Berkum, J. Alain Kummer

Blood (2002) 99 (1): 232–237.

https://doi.org/10.1182/blood.V99.1.232

Published: 2002

Journal Articles

Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma

Rosita L. ten Berge, Danny F. Dukers, Joost J. Oudejans, Karen Pulford, Gert J. Ossenkoppele, Daphne de Jong, Jo F.M.M. Miseré, Chris J.L.M. Meijer

Blood (1999) 93 (8): 2688–2696.

https://doi.org/10.1182/blood.V93.8.2688

Published: 1999

NARROW

Bortezomib Restores Defective Apoptosis by Upregulation of Noxa in Enteropathy-Associated T-Cell Lymphoma

Bortezomib Induces Caspase-9-Mediated Apoptosis through Activation of the BH3-Only Proteins Noxa, Bik and Puma In Both ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma Cells

Enteropathy-Associated T-Cell Lymphoma: a Clinical Prognostic Model to Identify High Risk Patients

Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression

Small-molecule XIAP antagonist restores caspase-9–mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity.

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas

Profiling of Caspase Signaling Pathways Predicts Clinical Response to Chemotherapy in Diffuse Large B-Cell Lymphomas.

High numbers of active caspase 3–positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome

Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only